RLYB - Rallybio Corp
10.505
-0.200 -1.904%
Share volume: 266,294
Last Updated: 03-04-2026
Pharmaceutical Products/Pharmaceutical Preparations:
3.72%
PREVIOUS CLOSE
CHG
CHG%
$10.70
0.00
0.00%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | 03-31-2025 | 09-30-2025 | |
|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q3 2025 | |
| Report Date | 05-09-2024 | 08-08-2024 | 11-07-2024 | 03-13-2025 | 05-08-2025 | 11-06-2025 | |
| Total revenue | 0.000 | 299.000 K | 299.000 K | 2.000 K | 212.000 K | 212.000 K | |
| Cost of revenue | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Gross profit | 0.000 | 299.000 K | 299.000 K | 2.000 K | 212.000 K | 212.000 K | |
| inf% | 0.00% | -99.33% | 10,500.00% | 0.00% | |||
| Operating expenses | 19.787 M | 17.334 M | 12.365 M | 11.646 M | 9.882 M | 7.137 M | |
| Selling general and admin | 6.851 M | 4.388 M | 4.125 M | 4.261 M | 4.157 M | 2.994 M | |
| Research and development | 12.936 M | 12.946 M | 8.240 M | 7.385 M | 5.725 M | 4.143 M | |
| Total expenses | 19.787 M | 17.334 M | 12.365 M | 11.646 M | 9.882 M | 7.137 M | |
| -12.40% | -28.67% | -5.81% | -15.15% | -27.78% | |||
| Operating income | -19.787 M | -17.035 M | -12.066 M | -11.608 M | -9.670 M | -6.925 M | |
| Ebit | -19.706 M | -16.892 M | -11.815 M | -11.339 M | -9.496 M | 15.554 M | |
| Pretax income | -18.344 M | -15.749 M | -10.829 M | -10.614 M | -8.852 M | 16.016 M | |
| -14.15% | -31.24% | -1.99% | -16.60% | -280.93% | |||
| Income tax | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income basic | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income | -19.029 M | -16.236 M | -11.466 M | -11.044 M | -9.439 M | 16.016 M | |
| 14.68% | 29.38% | 3.68% | 14.53% | 269.68% |